BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yan C, Xue G, Zhao H, Feng Y, Li S, Cui J, Ni S, Sun H. Molecular and clinical characteristics of severe Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol 2019;54:1012-21. [DOI: 10.1002/ppul.24327] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Lin X, Khalaf OI. Analysis of Clinical Related Factors of Severe Mycoplasma pneumoniae Pneumonia in Children Based on Imaging Diagnosis. Computational and Mathematical Methods in Medicine 2022;2022:1-8. [DOI: 10.1155/2022/4852131] [Reference Citation Analysis]
2 Liu J, Wang M, Zhao Z, Lin X, Zhang P, Yue Q, Zhang T, Meng Y. Viral and bacterial coinfection among hospitalized children with respiratory tract infections. Am J Infect Control 2020;48:1231-6. [PMID: 32113661 DOI: 10.1016/j.ajic.2020.01.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ling Y, Zhang T, Guo W, Zhu Z, Tian J, Cai C, Xu Y. Identify clinical factors related to Mycoplasma pneumoniae pneumonia with hypoxia in children. BMC Infect Dis 2020;20:534. [PMID: 32698769 DOI: 10.1186/s12879-020-05270-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lee E, Lee YY. Predictive Factors of the Responses to Treatment of Mycoplasma pneumoniae Pneumonia. J Clin Med 2021;10:1154. [PMID: 33801856 DOI: 10.3390/jcm10061154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Rodman Berlot J, Krivec U, Mrvič T, Kogoj R, Keše D. Mycoplasma pneumoniae P1 Genotype Indicates Severity of Lower Respiratory Tract Infections in Children. J Clin Microbiol 2021;59:e0022021. [PMID: 33980654 DOI: 10.1128/JCM.00220-21] [Reference Citation Analysis]
6 Dumke R, Rodriguez N. Use of different approaches for the culture-independent typing of Mycoplasma pneumoniae from two geographically distinct regions. J Microbiol Methods 2021;186:106239. [PMID: 33991585 DOI: 10.1016/j.mimet.2021.106239] [Reference Citation Analysis]
7 Zhao F, Guan X, Li J, Liu L, Gong J, He L, Meng F, Zhang J. Real-Time PCR and Quantitative Culture for Mycoplasma pneumoniae Load in Pharyngeal Swabs from Children at Preliminary Diagnosis and Discharge. Biomed Res Int 2020;2020:9814916. [PMID: 31998803 DOI: 10.1155/2020/9814916] [Reference Citation Analysis]
8 Cho HK. Consideration in treatment decisions for refractory Mycoplasma pneumoniae pneumonia. Clin Exp Pediatr 2021;64:459-67. [PMID: 33561337 DOI: 10.3345/cep.2020.01305] [Reference Citation Analysis]
9 Rivaya B, Jordana-Lluch E, Fernández-Rivas G, Molinos S, Campos R, Méndez-Hernández M, Matas L. Macrolide resistance and molecular typing of Mycoplasma pneumoniae infections during a 4 year period in Spain. J Antimicrob Chemother 2020;75:2752-9. [PMID: 32653897 DOI: 10.1093/jac/dkaa256] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
10 Dumke R, Rust M, Glaunsinger T. MgpB Types among Mycoplasma genitalium Strains from Men Who Have Sex with Men in Berlin, Germany, 2016-2018. Pathogens 2019;9:E12. [PMID: 31861901 DOI: 10.3390/pathogens9010012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
11 Wang Y, Xu B, Wu X, Yin Q, Wang Y, Li J, Jiao W, Quan S, Sun L, Wang Y, Shen A. Increased Macrolide Resistance Rate of M3562 Mycoplasma pneumoniae Correlated With Macrolide Usage and Genotype Shifting. Front Cell Infect Microbiol 2021;11:675466. [PMID: 34055671 DOI: 10.3389/fcimb.2021.675466] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yin L, Ma Y, Wang W, Zhu Y. The critical function of miR-1323/Il6 axis in children with Mycoplasma pneumoniae pneumonia. J Pediatr (Rio J) 2021;97:552-8. [PMID: 33347836 DOI: 10.1016/j.jped.2020.11.004] [Reference Citation Analysis]
13 Zhao F, Liu J, Xiao D, Liu L, Gong J, Xu J, Li H, Zhao S, Zhang J. Pathogenic Analysis of the Bronchoalveolar Lavage Fluid Samples With Pediatric Refractory Mycoplasma pneumoniae Pneumonia. Front Cell Infect Microbiol 2020;10:553739. [PMID: 33194797 DOI: 10.3389/fcimb.2020.553739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Loconsole D, De Robertis AL, Sallustio A, Centrone F, Morcavallo C, Campanella S, Accogli M, Chironna M. Update on the Epidemiology of Macrolide-Resistant Mycoplasma pneumoniae in Europe: A Systematic Review. Infect Dis Rep 2021;13:811-20. [PMID: 34562998 DOI: 10.3390/idr13030073] [Reference Citation Analysis]
15 Zhu Z, Zhang T, Guo W, Ling Y, Tian J, Xu Y. Clinical characteristics of refractory mycoplasma pneumoniae pneumonia in children treated with glucocorticoid pulse therapy. BMC Infect Dis 2021;21:126. [PMID: 33509121 DOI: 10.1186/s12879-021-05830-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 He H, Wang X, Xiao Y, Zheng J, Wang J, Zhang B. Comparative efficacy and safety of traditional Chinese patent medicine in the treatment of Mycoplasma pneumoniae pneumonia in children: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e23747. [PMID: 33371133 DOI: 10.1097/MD.0000000000023747] [Reference Citation Analysis]
17 Xiao L, Ratliff AE, Crabb DM, Mixon E, Qin X, Selvarangan R, Tang YW, Zheng X, Dien Bard J, Hong T, Prichard M, Brooks E, Dallas S, Duffy LB, Fowler KB, Atkinson TP, Waites KB. Molecular Characterization of Mycoplasma pneumoniae Isolates in the United States from 2012 to 2018. J Clin Microbiol 2020;58:e00710-20. [PMID: 32817226 DOI: 10.1128/JCM.00710-20] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]